The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research | Schizophrenia
Medical | PDF | American Medical Association | Pharmacology
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
Criteria indicating treatment-resistant schizophrenia, and proxy... | Download Scientific Diagram
Case study: treatment-resistant schizophrenia - The Pharmaceutical Journal
Frontiers | N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia | SpringerLink
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series
PDF) Receptor Mechanisms in the treatment of Schizophrenia
Delaying clozapine: how long is too long? | General Psychiatry
Treatment-Resistant Schizophrenia Guideline | Psychiatrist.com
UNIVERSIDADE DE LISBOA FACULDADE DE FARMÁCIA STUDY OF THE UNDERLYING BASIS FOR VALPROATE HEPATOTOXICITY: DRUG METABOLISM AND
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry
Annual Report 2008 - Istituto di Ricerche Farmacologiche Mario Negri
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
PDF) N -Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials | SpringerLink
PDF) Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
